WeedMD Launches Cannabis 2.0 Product Line of Medical Vaporizers

Published: June 24, 2020

WeedMD Launches Cannabis 2.0 Product Line of Medical Vaporizers

WeedMD Inc., a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce the launch of its innovative line of strain-specific medicinal vaporizer pens (vapes). The ‘Aurum’ vapes are available to Starseed patients across Canada as part of the Company’s expanding medical cannabis product portfolio as an insured benefit. WeedMD’s medical vaporization product line will be available to medical patients in the coming weeks and will expand into the adult-use market under its Color Cannabis brand in Q3, 2020.

Produced in-house at WeedMD’s extraction hub CX Industries, Aurum vape cartridges are filled with cannabis concentrates processed from biomass cultivated from the Company’s indoor and outdoor harvests. The strain-specific product line launches with Ghost Train Haze, followed by Mango Haze and soon thereafter a high CBD-strain format.

“Our Cannabis 2.0 strategy evolved after thoughtful consideration of our medical clients’ need for relief from specific indications that may require precise cannabis dosing via alternate delivery methods,” said Angelo Tsebelis, CEO of WeedMD. “When paired with our in-house talent in cultivating, extracting and processing, we developed Aurum as a perfect alternative consumption method. In keeping with our medical roots, we are proud to launch Aurum as a refined medical product that complements our quality-produced portfolio. As an added benefit, in addition to expanding our Aurum product offerings with innovative Cannabis 2.0 formats in the coming months, we will launch a vape product line for the adult-use market under the Color Cannabis brand in the third quarter of this year.”

The Aurum vape hardware is powered by New York-based innovators the Blinc Group, designers of premium customized vaporizers. The sleekly designed units are manufactured to the highest international standards of safety and compliance. The cartridges and batteries contain an industry-standard 510 thread, ensuring compatibility with most other standard 510 threaded cartridges and batteries.

“In developing and producing Aurum vapes – health, safety, and quality are our top priorities,” said Moe Jiwan, Chief Customer Officer, WeedMD. “Aurum is the finished product of many months of testing, perfecting formulations and collaborating between our team and our partner, the Blinc Group, to ensure we deliver a safe and high-quality product to our patients. We are excited to launch Aurum Vapes as we continue to develop unique brands and formulations that offer more choices and, most importantly, access to safe, quality-tested medical cannabis products.”

Aurum vapes will adhere to the Starseed System™ which simplifies the dialogue around strength and dosage by categorizing medical cannabis according to THC and CBD levels. The new vapes will be launching with Aurum 4, a THC-dominant concentrate, with subsequent releases of Aurum 2, offering a balance of CDB/THC, and Aurum 1 a CBD-dominant concentrate. The batteries and cartridges will be available as a kit which will include the cartridge, battery, and a USB charger. The Starseed product development and innovation team, as well as the Quality Assurance department have taken all necessary precautions to ensure product satisfaction and formulation testing. The hardware development was completed to the highest standards, in accordance with Current Good Manufacturing Practices (cGMP) and Restriction of Hazardous Substances (RoHS) and in accordance with regulation requirements.

WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., federally-licensed producers of cannabis products for both the medical and adult-use markets.